The following are recent financial reports as posted by selected Utah corporations:
Green Dot
Green Dot Corp., based in Provo, reported net income of $5.1 million, or 9 cents per share, for the fourth quarter ended Dec. 31. That compares with a net loss of $23.6 million, or 45 cents per share, for the same quarter a year earlier.
Operating revenues in the most recent quarter totaled $455 million, up from $366 million in the year-earlier quarter.
For the full year 2024, the company reported a net loss of $26.7 million, or 50 cents per share. That compares with net income of $6.7 million, or 13 cents per share, for 2023. For the full year 2024, operating revenues totaled $1.72 billion, up from $1.5 billion in 2023.
Green Dot is a financial technology platform and registered bank holding company that builds banking and payment solutions.
“It was a solid year and fourth quarter for Green Dot as we accelerated revenue and earnings growth and saw our first positive quarter of account growth in several years,” George Gresham, CEO, said in announcing the results. “We balanced the impact of ongoing headwinds with operational improvements and growth in our B2B and embedded finance businesses, aided by new partner wins including Varo, Clip Money, DolFintech and others, reflecting the increasing demand and growth opportunity in embedded finance and Green Dot’s unique value proposition.
“This reinforces our investments in Arc, our embedded finance brand and platform, and further bolsters my confidence in our growth strategy and path forward.”
Myriad Genetics
Myriad Genetics Inc., based in Salt Lake City, reported a net loss of $42.5 million, or 47 cents per share, for the fourth quarter ended Dec. 31. That compares with a loss of $31.2 million, or 36 cents per share, for the same quarter a year earlier.
Revenue in the most recent quarter totaled $210.6 million, up from $196.6 million for the year-earlier quarter.
For the full year 2024, the company reported a net loss of $127.3 million, or $1.41 per share. That compares with a loss of $263.3 million, or $3.18 per share, for 2023. Revenue in 2024 totaled $837.6 million, up from $753.2 million in 2023.
Myriad Genetics is a molecular diagnostic testing and precision medicine company.
“There is a lot for Myriad Genetics to be proud of in 2024,” Paul J. Diaz, president and CEO, said in announcing the results. “We generated 11 percent revenue growth over 2023, making this our second consecutive year of double-digit growth, and $40 million in adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). This achievement is the result of the company’s multi-year investment strategy along with our team’s hard work and focus on the needs of our patients and the health care providers who serve them.”
Purple
Purple Innovation Inc., based in Lehi, reported a net loss of $8.5 million, or 8 cents per share, for the fourth quarter ended Dec. 31. That compares with a loss of $18.3 million, or 17 cents per share, for the same quarter a year earlier.
Revenue in the most recent quarter totaled $129 million, down from $145.9 million in the year-earlier quarter.
For the full year 2024, the company reported a net loss of $97.9 million, or 91 cents per share. That compares with a loss of $120.8 million, or $1.17 per share, for 2023.
Net revenue in 2024 totaled $487.9 million, down from $510.5 million in 2023.
Purple manufactures mattresses, pillows, cushions, frames, sheets and other Please log in to see the rest of this story.
